Recombinant LAG3 (Favezelimab Biosimilar) antibody

Catalog No. ABIN7597686

This Humanized Chimeric antibody specifically detects LAG3 (Favezelimab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant LAG3 (Favezelimab Biosimilar) antibody (ABIN7597686)

Target: LAG3 (Favezelimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This LAG3 (Favezelimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-LAG3 (Favezelimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Favezelimab Biosimilar Antibody

Specificity: FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for LAG3 (Favezelimab Biosimilar)

Target: LAG3 (Favezelimab Biosimilar)

Alternative Name: Favezelimab Biosimilar

Target Type: Biosimilar

Background: FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3

UniProt: P18627